[Evaluation of 2 new emebicides in view of a rigid criteria of recovery].
D000562:Amebiasis / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D004404:Dysentery, Amebic; D006801:Humans; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D000904:Antibiotics, Antitubercular; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline
AMEBIASIS/therapy; ANTIBIOTICS/therapeutic use; ANTISEPTICS/therapeutic use; TETRACYCLINE/therapeutic use
La evaluación de dos nuevos amebicidas a la luz de un criterio regido de cura.